Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat

G. R. Trimarchi, C. Imperatore, F. A. Arcadi, A. Saija, A. De Sarro, G. B. De Sarro, G. Costa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We sought to determine whether differences in cardiovascular responsiveness to central stimulation of the cholinergic system existed between the genetically epilepsy-prone and outbred Sprague-Dawley rats. We treated the unanaesthetized, restrained rats with the indirect cholinergic agonist physostigmine (25, 50, 100 and 200 μg kg-1,i.v.)and the direct muscarinic agonist arecoline (50, 100 and 200 μg kg-1, i.v.). Blood pressure and heart rate were evaluated. Genetically epilepsy-prone rats demonstrated to be more susceptible to the action of physostigmine than the outbred Sprague-Dawley rats. Conversely, we did not note any difference between the two strains in the extent of the pressor response induced by arecoline. Moreover, we treated both strains with hemicholinium-3 (34.8 nmol, i.c.v.) to deplete endogenous stores of acetylcholine. This treatment did not affect the pressor response to arecoline, whereas it greatly reduced the response to physostigmine. The present results support an increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat which appears to be related to a pre-synaptic rather than a post-synaptic component.

Original languageEnglish
Pages (from-to)497-502
Number of pages6
JournalJournal of Pharmacy and Pharmacology
Volume46
Issue number6
Publication statusPublished - 1994

Fingerprint

Arecoline
Physostigmine
Cholinergic Agents
Epilepsy
Sprague Dawley Rats
Hemicholinium 3
Cholinergic Agonists
Muscarinic Agonists
Acetylcholine
Heart Rate
Blood Pressure

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Trimarchi, G. R., Imperatore, C., Arcadi, F. A., Saija, A., De Sarro, A., De Sarro, G. B., & Costa, G. (1994). Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat. Journal of Pharmacy and Pharmacology, 46(6), 497-502.

Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat. / Trimarchi, G. R.; Imperatore, C.; Arcadi, F. A.; Saija, A.; De Sarro, A.; De Sarro, G. B.; Costa, G.

In: Journal of Pharmacy and Pharmacology, Vol. 46, No. 6, 1994, p. 497-502.

Research output: Contribution to journalArticle

Trimarchi, GR, Imperatore, C, Arcadi, FA, Saija, A, De Sarro, A, De Sarro, GB & Costa, G 1994, 'Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat', Journal of Pharmacy and Pharmacology, vol. 46, no. 6, pp. 497-502.
Trimarchi GR, Imperatore C, Arcadi FA, Saija A, De Sarro A, De Sarro GB et al. Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat. Journal of Pharmacy and Pharmacology. 1994;46(6):497-502.
Trimarchi, G. R. ; Imperatore, C. ; Arcadi, F. A. ; Saija, A. ; De Sarro, A. ; De Sarro, G. B. ; Costa, G. / Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat. In: Journal of Pharmacy and Pharmacology. 1994 ; Vol. 46, No. 6. pp. 497-502.
@article{844aaea0dc4746d89b6e6719e68b816d,
title = "Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat",
abstract = "We sought to determine whether differences in cardiovascular responsiveness to central stimulation of the cholinergic system existed between the genetically epilepsy-prone and outbred Sprague-Dawley rats. We treated the unanaesthetized, restrained rats with the indirect cholinergic agonist physostigmine (25, 50, 100 and 200 μg kg-1,i.v.)and the direct muscarinic agonist arecoline (50, 100 and 200 μg kg-1, i.v.). Blood pressure and heart rate were evaluated. Genetically epilepsy-prone rats demonstrated to be more susceptible to the action of physostigmine than the outbred Sprague-Dawley rats. Conversely, we did not note any difference between the two strains in the extent of the pressor response induced by arecoline. Moreover, we treated both strains with hemicholinium-3 (34.8 nmol, i.c.v.) to deplete endogenous stores of acetylcholine. This treatment did not affect the pressor response to arecoline, whereas it greatly reduced the response to physostigmine. The present results support an increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat which appears to be related to a pre-synaptic rather than a post-synaptic component.",
author = "Trimarchi, {G. R.} and C. Imperatore and Arcadi, {F. A.} and A. Saija and {De Sarro}, A. and {De Sarro}, {G. B.} and G. Costa",
year = "1994",
language = "English",
volume = "46",
pages = "497--502",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "6",

}

TY - JOUR

T1 - Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat

AU - Trimarchi, G. R.

AU - Imperatore, C.

AU - Arcadi, F. A.

AU - Saija, A.

AU - De Sarro, A.

AU - De Sarro, G. B.

AU - Costa, G.

PY - 1994

Y1 - 1994

N2 - We sought to determine whether differences in cardiovascular responsiveness to central stimulation of the cholinergic system existed between the genetically epilepsy-prone and outbred Sprague-Dawley rats. We treated the unanaesthetized, restrained rats with the indirect cholinergic agonist physostigmine (25, 50, 100 and 200 μg kg-1,i.v.)and the direct muscarinic agonist arecoline (50, 100 and 200 μg kg-1, i.v.). Blood pressure and heart rate were evaluated. Genetically epilepsy-prone rats demonstrated to be more susceptible to the action of physostigmine than the outbred Sprague-Dawley rats. Conversely, we did not note any difference between the two strains in the extent of the pressor response induced by arecoline. Moreover, we treated both strains with hemicholinium-3 (34.8 nmol, i.c.v.) to deplete endogenous stores of acetylcholine. This treatment did not affect the pressor response to arecoline, whereas it greatly reduced the response to physostigmine. The present results support an increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat which appears to be related to a pre-synaptic rather than a post-synaptic component.

AB - We sought to determine whether differences in cardiovascular responsiveness to central stimulation of the cholinergic system existed between the genetically epilepsy-prone and outbred Sprague-Dawley rats. We treated the unanaesthetized, restrained rats with the indirect cholinergic agonist physostigmine (25, 50, 100 and 200 μg kg-1,i.v.)and the direct muscarinic agonist arecoline (50, 100 and 200 μg kg-1, i.v.). Blood pressure and heart rate were evaluated. Genetically epilepsy-prone rats demonstrated to be more susceptible to the action of physostigmine than the outbred Sprague-Dawley rats. Conversely, we did not note any difference between the two strains in the extent of the pressor response induced by arecoline. Moreover, we treated both strains with hemicholinium-3 (34.8 nmol, i.c.v.) to deplete endogenous stores of acetylcholine. This treatment did not affect the pressor response to arecoline, whereas it greatly reduced the response to physostigmine. The present results support an increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat which appears to be related to a pre-synaptic rather than a post-synaptic component.

UR - http://www.scopus.com/inward/record.url?scp=0028362667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028362667&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 497

EP - 502

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 6

ER -